Trial Profile
Clinical Trials Insight: 700017407
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 02 Nov 2006
Price :
$35
*
At a glance
- Drugs Dulanermin (Primary)
- Indications Cancer
- Focus Registrational; Therapeutic Use
- Sponsors Aida Pharmaceuticals
- 02 Nov 2006 New trial record.